Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,728.50
Bid: 1,727.00
Ask: 1,728.00
Change: 23.50 (1.38%)
Spread: 1.00 (0.058%)
Open: 1,705.00
High: 1,729.50
Low: 1,695.50
Prev. Close: 1,705.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-Kenya becomes third African nation to introduce malaria vaccine

Fri, 13th Sep 2019 13:56

(Adds details of vaccine, statement from WHO Africa director)

NAIROBI, Sept 13 (Reuters) - Kenya on Friday began adding a
malaria vaccine to its routine immunization schedule for babies
and toddlers, becoming the third African country to roll out the
vaccine for a disease that threatens children across the
continent.

Malaria, which kills one child globally every two minutes,
is the top killer of children under five in the east African
country. The vaccine - the world's first against malaria - will
be administered to children under two and could be crucial to
efforts to combat the disease, health officials said.

Other measures, such as nets to protect people from the
mosquitoes that carry the malaria parasite, have not proven
adequate to halt transmission, the director general of Kenya's
health ministry, Wekesa Masasabi, told Reuters.

"We still have an incidence of 27% (malaria infection) for
children under five," Masasabi said before Friday's launch of
the vaccine in the western county of Homa Bay.

The Homa Bay programme is the government's first step toward
creating awareness of the new vaccine, he said.

The injectable vaccine, called RTS,S or Mosquirix, was
developed by British drugmaker GlaxoSmithKline to
protect children from the most deadly form of malaria in Africa.

In clinical trials it proved only partially effective and it
needs to be given in a four-dose schedule, but it is the first
regulator-approved vaccine against the disease.

It has already been deployed in pilot programmes in Ghana
and Malawi.

Malaria infected about 219 million people in 2017 and killed
around 435,000. The vast majority of malaria deaths are among
babies and children in the poorest parts of Africa. Due to
ongoing transmission, half the world's population is still at
risk of contracting the disease.

The World Health Organization's regional director for
Africa, Matshidiso Moeti, said the Kenyan, Ghanaian and Malawian
pilots would provide key information and data for a future WHO
policy on broader use of the vaccine in sub-Saharan Africa.

A recent surge in malaria cases and deaths in the region is
threatening gains in the fight against the disease, she said,
adding that the vaccine "has the potential to save tens of
thousands of lives."

Kenya plans to roll out RTS,S to eight of its 47 counties
over the next two years, Masasabi said.

In a major report published last weekend, global health
experts said malaria could be eradicated within a generation
with the right tools, funding and political will.

Commissioned by The Lancet medical journal, the report
contradicted the conclusions last month of a malaria review by
the WHO. The experts urged the U.N. agency not to shy away from
this "goal of epic proportions".
(Reporting by Maggie Fick in Niarobi and Kate Kelland in London
Editing by Tom Hogue and Frances Kerry)

More News
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.